Lipoflex Senza Elettroliti (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Lipoflex Senza Elettroliti is used in the context of parenteral nutrition to meet protein and amino‑acid requirements.

• Parenteral nutrition: supplies essential amino acids to patients requiring intravenous feeding.
• Critical care: supports metabolic demands in intensive‑care patients.
• Surgical recovery: aids protein synthesis during the postoperative period.

• The formulation delivers a balanced mixture of essential amino acids directly into the bloodstream, providing substrates for protein synthesis, maintaining nitrogen balance, and stimulating the mTOR pathway that regulates cellular growth. By bypassing the gastrointestinal tract, it meets the metabolic needs of patients who cannot tolerate oral or enteral nutrition.

Lipoflex Senza Elettroliti may be associated with infusion‑related reactions and metabolic changes.

Common Side Effects

• Mild infusion site irritation or pain.
• Transient increase in blood urea nitrogen.
• Slight electrolyte shifts, such as mild hypernatremia.
• Headache or dizziness during infusion.
• Nausea or mild gastrointestinal discomfort.

Serious or Rare Side Effects

• Anaphylactic or severe hypersensitivity reaction.
• Severe hyperammonemia in patients with hepatic impairment.
• Metabolic acidosis due to excessive amino‑acid load.
• Acute renal dysfunction or worsening of existing kidney disease.
• Thrombophlebitis or severe phlebitis at the infusion site.

When using Lipoflex Senza Elettroliti, clinicians should consider several safety measures.

• Assess renal function: adjust use in patients with renal impairment.
• Monitor liver function: watch for signs of hepatic overload.
• Check nitrogen balance: avoid excessive protein administration.
• Avoid use in individuals with known hypersensitivity to any amino acid component.
• Employ aseptic technique: prevent contamination of the sterile solution.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lipoflex Senza Elettroliti can interact with other therapies that affect nitrogen metabolism or renal function.

Major Interactions (Avoid)

• Concurrent high‑dose nitrogen‑scavenging agents (e.g., sodium phenylacetate) may lead to toxic accumulation.
• Co‑administration with nephrotoxic drugs (e.g., aminoglycosides) can exacerbate renal stress.

Moderate Interactions (Monitor Closely)

• Interaction with insulin therapy may alter glucose control; monitor blood sugar.
• Concurrent electrolyte solutions may require frequent serum electrolyte checks.
• Use with other parenteral nutrition components may need compatibility testing to prevent precipitation.